EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma

John Rieth iD, Varun Monga iD, Mohammed Milhem

Cancers · 01.04.2025 · 17 (7) · 1203

DOI: 10.3390/cancers17071203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 01.04.2025. Verfasst von John Rieth und 2 weiteren Autor:innen. Beteiligte Einrichtung: Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA 52242, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Despite conventional cytotoxic chemotherapy treatments, soft tissue sarcoma continues to remain a terminal diagnosis for most patients. Numerous chemotherapeutic agents have been trialed in soft tissue sarcoma, with marginal improvement in overall survival. Novel therapeutic approaches are needed to improve outcomes for this entity. Methods: the literature was reviewed, including a summary of pertinent adjuvant/neoadjuvant clinical trials and trials for metastatic disease.

Results

Chemotherapeutic agent use in adjuvant/neoadjuvant trials provided limited if any evidence of the benefit of chemotherapy in this space. Despite multiple trials in the metastatic space, novel chemotherapeutic agents appear to have limited long-term benefits for the management of soft tissue sarcoma. Suggestions for further research, particularly with neoadjuvant clinical trials, were made.

Conclusions

Chemotherapy remains an inadequate treatment option for soft tissue sarcoma, and novel therapies are needed. The neoadjuvant space provides an excellent opportunity to study the effects of innovative treatments in soft tissue sarcoma.

Schlagwörter

Stichwörter der Autor:innen

adjuvantchemotherapyimmunotherapymetastaticneoadjuvant keywordradiationsarcoma

Autor:innen und Institutionen

  • Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA 52242, USA.
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94158, USA.

ORCID-Profile: John Rieth, Varun Monga

Zitieren

APA

Rieth, J., Monga, V., & Milhem, M. (2025). The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma. Cancers, 17(7), 1203. https://doi.org/10.3390/cancers17071203

Vancouver

Rieth J, Monga V, Milhem M. The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma. Cancers. 2025;17(7):1203. doi:10.3390/cancers17071203

BibTeX
@article{Rieth2025,
  author = {Rieth, John and Monga, Varun and Milhem, Mohammed},
  title = {The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {1203},
  doi = {10.3390/cancers17071203}
}
Kostenlos starten →